AAV2-GDNF for Advanced Parkinson s Disease | MicrobiomeTrials← Back to trialsNCT01621581
AAV2-GDNF for Advanced Parkinson s Disease
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2013-03-13Est. Completion: 2022-02-04
Enrollment target: 25 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Parkinson's Disease
Background:
\- In deep brain stimulation (DBS), a device called a neurostimulator is placed in the chest. It is attache…
Bethesda, United StatesEst. completion Dec 1, 2030
StrokeParkinson Disease
This pilot feasibility study will evaluate a wearable soft elbow exosuit and a haptic forearm bracelet for upper-limb ne…
Cassino, ItalyEst. completion Dec 2026